Articles

Tesla’s stock continues to cruise — toward its 10th day in a row of gains

The stock has increased by more than 40% over the current 10-session stretch of gains.

‘I’m waiting for them to pay us to eat’: Fast-food chains are now offering items for as low as $1.99

Sonic and Subway have recently launched menu options in the $2 to $3 range.

Americans are going into debt for summer fun. Many will still be paying it off a year from now.

Many Americans are willing to take on debt to enjoy the summer but will end up carrying those balances with them for months — even years, in some cases — as they rack up interest at near record-high rates.

Boeing’s Q2 airplane deliveries dropped more than 30% from last year

Boeing reported second-quarter commercial airplane deliveries that improved from the previous quarter, helped by a strong June, but fell more than 30% from a year ago.

Jobs report is exaggerating U.S. employment gains. What is going on?

The crucial U.S. jobs report has developed a bad habit: It keeps exaggerating how many new jobs are created each month.

Fifth Third pays $20 million to resolve fake account and wrongful auto repossession charges

CFTC requires bank to pay back 35,000 ‘harmed’ customers including 1,000 wrongful car repossessions.

For these people, turning 65 means falling off the ‘Medicare cliff’

Losing Medicaid coverage leaves some older adults facing higher medical costs.

Amazon Prime Day will have more travel deals this year. Here are the good ones — and the ‘terrible’ ones.

Amazon Prime Day, which runs July 16 – 17, will have a landing page for travel deals.

Nvidia’s stock leads the S&P 500, but not all chip stocks are along for the ride

While Nvidia and Micron shares are among the index’s biggest daily gainers, AMD’s stock rally is taking a breather.

Silicon Valley Bank buyer First Citizens seen as value play among bigger firms

Jefferies initiates coverage of North Carolina-based lender with a buy rating

Salesforce and other software stocks are expected to bounce back in a big way

This year’s rally for technology stocks hasn’t been broad-based. Analysts see opportunities among some of the software companies that have been left behind.

Prescription-drug middlemen face more pressure from FTC in new report

The Federal Trade Commission on Tuesday ramped up the pressure on prescription-drug middlemen who influence the accessibility and affordability of medications.
1 838 839 840 841 842 2,159